Clinical Trial

SiREX-Stent for the Treatment of SymptOmatic Lateral VEnous Sinus Stenosis

Study acronym: RESOLVE
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the efficacy, safety and the clinical benefit of the SiREX stent for the treatment of disabling pulsatile tinnitus due to stenosis of lateral sinus. The study will enrol patients suffering from pulsatile tinnitus related to a lateral sinus stenosis lasting more than three months, and who want to be treated with lateral sinus stenting
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-05; most recent amendment 2025-08-27.
Status change: Not Yet Recruiting → Recruiting 2025-08-27
Trial Details
NCT Number NCT06726928
Lead Sponsor Acandis GmbH
Conditions Treatment of Symptomatic Lateral Sinus Stenosis, Treatment of Pulsatile Tinnitus Due tu Sinus Stenosis
Enrollment 78 participants
Start Date 2025-09
Primary Completion 2027-01 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-04